(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of PPARB mRNA] CTD PMID:31150632 (5Z,8Z,11Z,13E)-15-HETE multiple interactions ISO RGD:731946 6480464 15-hydroxy-5 more ... CTD PMID:12069687 (S)-naringenin multiple interactions EXP 6480464 HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARB protein]], naringenin inhibits the reaction [Glucose results in decreased expression of PPARB protein] CTD PMID:31063766 (S)-naringenin multiple interactions ISO RGD:731946 6480464 naringenin inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Carboxymethylcellulose Sodium] results in decreased expression of PPARB protein] CTD PMID:31063766 1,2-dimethylhydrazine decreases expression ISO RGD:731946 6480464 1, 2-Dimethylhydrazine results in decreased expression of PPARD mRNA CTD PMID:22206623 1,4-bis(2-ethylhexyl) sulfosuccinate increases activity ISO RGD:736289 6480464 Dioctyl Sulfosuccinic Acid results in increased activity of PPARD protein CTD PMID:26135921 15-deoxy-Delta(12,14)-prostaglandin J2 increases expression ISO RGD:736289 6480464 15-deoxy-delta(12, 14)-prostaglandin J2 results in increased expression of PPARD protein CTD PMID:17341418 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of PPARD mRNA CTD PMID:35192832 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:731946 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of PPARD mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PPARD mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:736289 6480464 Tetrachlorodibenzodioxin results in increased expression of PPARD mRNA, Tetrachlorodibenzodioxin results in increased expression of PPARD protein CTD PMID:21410761 , PMID:23152189 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:731946 6480464 Tetrachlorodibenzodioxin results in increased expression of PPARD mRNA CTD PMID:24058054 2,4-D multiple interactions ISO RGD:736289 6480464 PPARB protein affects the reaction [2 more ... CTD PMID:29633193 2,4-D increases expression ISO RGD:736289 6480464 2, 4-Dichlorophenoxyacetic Acid results in increased expression of PPARB mRNA CTD PMID:29633193 2-bromohexadecanoic acid multiple interactions ISO RGD:731946 6480464 2-bromopalmitate results in increased activity of [RXRA protein binds to PPARD protein] CTD PMID:15997096 2-bromohexadecanoic acid increases activity ISO RGD:736289 6480464 2-bromopalmitate results in increased activity of PPARD protein CTD PMID:21543282 , PMID:23150725 2-Ethylhexanoic acid affects expression EXP 6480464 2-ethylhexanoic acid affects the expression of PPARD mRNA, 2-ethylhexanoic acid affects the expression of PPARD protein CTD PMID:15647598 2-hydroxypropanoic acid decreases expression ISO RGD:736289 6480464 Lactic Acid results in decreased expression of PPARD mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A multiple interactions EXP 6480464 tetrabromobisphenol A inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARD mRNA] CTD PMID:25048947 3,3',5,5'-tetrabromobisphenol A multiple interactions ISO RGD:736289 6480464 tetrabromobisphenol A binds to and results in increased activity of PPARD protein CTD PMID:34627044 3,3',5-triiodo-L-thyronine multiple interactions ISO RGD:736289 6480464 [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA more ... CTD PMID:33476690 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:736289 6480464 [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA more ... CTD PMID:33476690 4,4'-sulfonyldiphenol multiple interactions ISO RGD:736289 6480464 bis(4-hydroxyphenyl)sulfone binds to and results in increased activity of PPARD protein CTD PMID:34627044 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PPARD mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol increases methylation ISO RGD:731946 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of PPARD gene CTD PMID:31683443 4,4'-sulfonyldiphenol decreases methylation ISO RGD:731946 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of PPARD exon CTD PMID:33297965 4,4'-sulfonyldiphenol increases expression ISO RGD:736289 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of PPARD mRNA CTD PMID:33885253 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of PPARD mRNA CTD PMID:24780913 9E,11E-octadecadienoic acid affects binding ISO RGD:736289 6480464 9, 11-linoleic acid binds to PPARB protein CTD PMID:23843199 acetylsalicylic acid decreases activity ISO RGD:736289 6480464 Aspirin results in decreased activity of PPARD protein CTD PMID:15646027 acetylsalicylic acid increases expression EXP 6480464 Aspirin results in increased expression of PPARD mRNA CTD PMID:12800193 acetylsalicylic acid increases expression ISO RGD:736289 6480464 Aspirin results in increased expression of PPARD mRNA CTD PMID:15646027 acetylsalicylic acid decreases expression ISO RGD:736289 6480464 Aspirin results in decreased expression of PPARD protein CTD PMID:18678619 acrylamide decreases expression ISO RGD:731946 6480464 Acrylamide results in decreased expression of PPARD mRNA CTD PMID:30807115 aflatoxin B1 increases methylation ISO RGD:736289 6480464 Aflatoxin B1 results in increased methylation of PPARD intron CTD PMID:30157460 aldehydo-D-glucose affects expression EXP 6480464 Glucose affects the expression of PPARD mRNA CTD PMID:24349266 aldehydo-D-glucose multiple interactions EXP 6480464 HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARB protein]], naringenin inhibits the reaction [Glucose results in decreased expression of PPARB protein] CTD PMID:31063766 aldehydo-D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of PPARB protein CTD PMID:31063766 aldehydo-D-glucose multiple interactions ISO RGD:736289 6480464 [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA CTD PMID:32613381 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of PPARD mRNA CTD PMID:24977338 all-trans-retinoic acid increases expression ISO RGD:736289 6480464 Tretinoin results in increased expression of PPARD mRNA CTD PMID:23724009 , PMID:33167477 alpha-linolenic acid multiple interactions ISO RGD:731946 6480464 alpha-Linolenic Acid binds to and results in increased activity of PPARB protein CTD PMID:16731579 alpha-linolenic acid increases expression ISO RGD:736289 6480464 alpha-Linolenic Acid results in increased expression of PPARD mRNA, Calcitriol results in increased expression of [alpha-Linolenic Acid results in increased expression of PPARD mRNA] CTD PMID:19667161 alpha-linolenic acid multiple interactions EXP 6480464 alpha-Linolenic Acid binds to and results in increased activity of PPARB protein CTD PMID:16731579 alpha-linolenic acid multiple interactions ISO RGD:736289 6480464 alpha-Linolenic Acid binds to and results in increased activity of PPARB protein CTD PMID:16731579 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of PPARD mRNA CTD PMID:16483693 androgen antagonist multiple interactions EXP 6480464 [Pesticides co-treated with Phthalic Acids co-treated with Androgen Antagonists] results in increased expression of PPARD mRNA CTD PMID:29945228 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:736289 6480464 pyrazolanthrone inhibits the reaction [Indomethacin results in increased expression of PPARD protein] CTD PMID:17341418 antimonite increases expression ISO RGD:736289 6480464 antimonite results in increased expression of PPARD mRNA CTD PMID:17400267 antimonite multiple interactions ISO RGD:736289 6480464 RTKI cpd inhibits the reaction [antimonite results in increased expression of PPARD mRNA] CTD PMID:17400267 antimycin A decreases expression ISO RGD:736289 6480464 Antimycin A results in decreased expression of PPARD mRNA CTD PMID:33512557 antirheumatic drug decreases expression ISO RGD:736289 6480464 Antirheumatic Agents results in decreased expression of PPARD mRNA CTD PMID:24449571 arachidonic acid increases expression ISO RGD:736289 6480464 Arachidonic Acid results in increased expression of PPARD mRNA CTD PMID:11172467 aristolochic acid A increases expression ISO RGD:736289 6480464 aristolochic acid I results in increased expression of PPARD mRNA CTD PMID:33212167 arsenite(3-) increases expression ISO RGD:736289 6480464 arsenite results in increased expression of PPARD mRNA CTD PMID:17400267 arsenite(3-) multiple interactions ISO RGD:736289 6480464 RTKI cpd inhibits the reaction [arsenite results in increased expression of PPARD mRNA] CTD PMID:17400267 aspartame multiple interactions ISO RGD:731946 6480464 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARD mRNA CTD PMID:23783067 azoxystrobin multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PPARD mRNA CTD PMID:33854195 benzo[a]pyrene increases expression ISO RGD:731946 6480464 Benzo(a)pyrene results in increased expression of PPARD mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO RGD:736289 6480464 Benzo(a)pyrene affects the methylation of PPARD promoter CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:736289 6480464 Benzo(a)pyrene results in decreased expression of PPARD mRNA CTD PMID:20064835 benzo[b]fluoranthene decreases expression ISO RGD:731946 6480464 benzo(b)fluoranthene results in decreased expression of PPARD mRNA CTD PMID:26377693 Benzo[k]fluoranthene increases expression ISO RGD:731946 6480464 benzo(k)fluoranthene results in increased expression of PPARD mRNA CTD PMID:26377693 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PPARD mRNA CTD PMID:18164116 bezafibrate multiple interactions ISO RGD:736289 6480464 Bezafibrate results in increased activity of [PPARD protein binds to RXRA protein], Calcitriol promotes the reaction [Bezafibrate results in increased expression of PPARD mRNA] CTD PMID:11779144 , PMID:19667161 bezafibrate multiple interactions EXP 6480464 Bezafibrate inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in decreased expression of PPARB mRNA] CTD PMID:26190035 bezafibrate increases expression ISO RGD:736289 6480464 Bezafibrate results in increased expression of PPARD mRNA, Bezafibrate results in increased expression of PPARD protein CTD PMID:11172467 more ... bezafibrate affects binding ISO RGD:736289 6480464 Bezafibrate binds to PPARB protein, Bezafibrate binds to PPARD protein CTD PMID:11779144 , PMID:23843199 bezafibrate increases activity EXP 6480464 Bezafibrate results in increased activity of PPARD protein CTD PMID:10585473 bezafibrate decreases expression ISO RGD:731946 6480464 Bezafibrate results in decreased expression of PPARD mRNA CTD PMID:19124612 bezafibrate increases expression ISO RGD:731946 6480464 Bezafibrate results in increased expression of PPARD, Bezafibrate results in increased expression of PPARD mRNA CTD PMID:19201410 , PMID:19214135 bezafibrate affects binding ISO RGD:731946 6480464 Bezafibrate binds to PPARD protein CTD PMID:12782154 , PMID:21687928 bezafibrate multiple interactions ISO RGD:731946 6480464 PPARD protein affects the reaction [Bezafibrate results in decreased expression of APOB mRNA alternative form] more ... CTD PMID:12782154 bifenthrin affects binding ISO RGD:736289 6480464 bifenthrin binds to PPARD protein CTD PMID:32278787 bis(2-ethylhexyl) phthalate increases expression ISO RGD:736289 6480464 Diethylhexyl Phthalate results in increased expression of PPARD protein CTD PMID:16455614 bis(2-ethylhexyl) phthalate affects binding ISO RGD:736289 6480464 Diethylhexyl Phthalate binds to PPARB protein CTD PMID:23843199 bis(2-ethylhexyl) phthalate affects expression EXP 6480464 Diethylhexyl Phthalate affects the expression of PPARD mRNA, Diethylhexyl Phthalate affects the expression of PPARD protein CTD PMID:15647598 bisphenol A affects methylation ISO RGD:731946 6480464 bisphenol A affects the methylation of PPARD promoter CTD PMID:27334623 bisphenol A decreases methylation ISO RGD:736289 6480464 bisphenol A results in decreased methylation of PPARD gene CTD PMID:31601247 bisphenol A multiple interactions ISO RGD:736289 6480464 bisphenol A binds to and results in increased activity of PPARD protein CTD PMID:34627044 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of PPARD mRNA CTD PMID:23399309 more ... bisphenol A affects binding ISO RGD:736289 6480464 bisphenol A analog binds to PPARD protein, bisphenol A binds to PPARB protein CTD PMID:23843199 , PMID:29925285 bisphenol A increases expression ISO RGD:736289 6480464 bisphenol A results in increased expression of PPARB mRNA CTD PMID:25619500 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PPARD mRNA, Wortmannin inhibits the reaction [bisphenol A results in decreased expression of PPARD mRNA] CTD PMID:23399309 , PMID:36041667 bisphenol A increases expression ISO RGD:731946 6480464 bisphenol A results in increased expression of PPARD mRNA, bisphenol A results in increased expression of PPARD protein CTD PMID:21932408 , PMID:31319301 Bisphenol B multiple interactions ISO RGD:736289 6480464 bisphenol B binds to and results in increased activity of PPARD protein CTD PMID:34627044 bisphenol F multiple interactions ISO RGD:736289 6480464 bisphenol F binds to and results in increased activity of PPARD protein CTD PMID:34627044 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of PPARD mRNA CTD PMID:36041667 bortezomib increases response to substance ISO RGD:736289 6480464 PPARD gene SNP results in increased susceptibility to Bortezomib CTD PMID:20864405 butanal increases expression ISO RGD:736289 6480464 butyraldehyde results in increased expression of PPARD mRNA CTD PMID:26079696 Butylbenzyl phthalate affects binding ISO RGD:736289 6480464 butylbenzyl phthalate binds to PPARB protein CTD PMID:23843199 butyric acid increases expression EXP 6480464 Butyric Acid results in increased expression of PPARD mRNA CTD PMID:12800193 cadmium atom multiple interactions ISO RGD:736289 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPARD mRNA CTD PMID:35301059 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of PPARD promoter CTD PMID:22457795 cadmium dichloride multiple interactions ISO RGD:736289 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of PPARD mRNA CTD PMID:35301059 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of PPARD mRNA CTD PMID:33453195 calcitriol multiple interactions ISO RGD:736289 6480464 [Calcitriol co-treated with GW 501516] results in increased expression of PPARD mRNA more ... CTD PMID:19667161 calcitriol increases expression ISO RGD:736289 6480464 Calcitriol results in increased expression of [alpha-Linolenic Acid results in increased expression of PPARD mRNA], Calcitriol results in increased expression of PPARD mRNA CTD PMID:15890193 , PMID:19667161 cannabidiol affects methylation EXP 6480464 Cannabidiol affects the methylation of PPARD gene CTD PMID:30521419 cannabidiol increases expression ISO RGD:736289 6480464 Cannabidiol results in increased expression of PPARD mRNA CTD PMID:31518892 capsaicin decreases expression ISO RGD:736289 6480464 Capsaicin results in decreased expression of PPARD mRNA CTD PMID:18769453 carbon nanotube decreases expression ISO RGD:731946 6480464 Nanotubes, Carbon analog results in decreased expression of PPARD mRNA CTD PMID:25620056 casticin decreases expression ISO RGD:736289 6480464 casticin results in decreased expression of PPARD mRNA CTD PMID:27862857 celecoxib decreases expression ISO RGD:736289 6480464 Celecoxib analog results in decreased expression of PPARD protein, Celecoxib results in decreased expression of PPARD protein CTD PMID:19682443 CGP 52608 multiple interactions ISO RGD:736289 6480464 CGP 52608 promotes the reaction [RORA protein binds to PPARD gene] CTD PMID:28238834 CHIR 99021 decreases expression ISO RGD:731946 6480464 Chir 99021 results in decreased expression of PPARD mRNA CTD PMID:29883716 chlorpyrifos multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PPARD mRNA CTD PMID:33854195 cilnidipine decreases activity ISO RGD:736289 6480464 cilnidipine results in decreased activity of PPARD protein CTD PMID:25257666 cisplatin increases expression ISO RGD:736289 6480464 Cisplatin results in increased expression of PPARD mRNA CTD PMID:33545341 clofibrate multiple interactions ISO RGD:736289 6480464 Clofibrate results in increased activity of [PPARD protein binds to RXRA protein] CTD PMID:11779144 clofibric acid affects binding ISO RGD:736289 6480464 Clofibric Acid binds to PPARD protein CTD PMID:11779144 Clofop multiple interactions ISO RGD:736289 6480464 fenofibric acid results in increased activity of [PPARD protein binds to RXRA protein] CTD PMID:11779144 cobalt dichloride decreases expression ISO RGD:736289 6480464 cobaltous chloride results in decreased expression of PPARD mRNA CTD PMID:15708366 conjugated linoleic acid multiple interactions ISO RGD:731946 6480464 Linoleic Acids, Conjugated binds to and results in increased activity of PPARB protein CTD PMID:16731579 conjugated linoleic acid multiple interactions EXP 6480464 Linoleic Acids, Conjugated binds to and results in increased activity of PPARB protein CTD PMID:16731579 conjugated linoleic acid multiple interactions ISO RGD:736289 6480464 Linoleic Acids, Conjugated binds to and results in increased activity of PPARB protein CTD PMID:16731579 copper(II) sulfate increases expression ISO RGD:736289 6480464 Copper Sulfate results in increased expression of PPARD mRNA CTD PMID:19549813 cortisol multiple interactions ISO RGD:736289 6480464 [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA more ... CTD PMID:33476690 crocidolite asbestos affects expression ISO RGD:736289 6480464 Asbestos, Crocidolite affects the expression of PPARD mRNA CTD PMID:17331233 curcumin decreases expression ISO RGD:736289 6480464 Curcumin results in decreased expression of PPARD mRNA, Curcumin results in decreased expression of PPARD protein CTD PMID:19294764 cyclosporin A increases expression ISO RGD:736289 6480464 Cyclosporine results in increased expression of PPARD mRNA CTD PMID:20106945 , PMID:25562108 D-glucose affects expression EXP 6480464 Glucose affects the expression of PPARD mRNA CTD PMID:24349266 D-glucose multiple interactions EXP 6480464 HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARB protein]], naringenin inhibits the reaction [Glucose results in decreased expression of PPARB protein] CTD PMID:31063766 D-glucose decreases expression EXP 6480464 Glucose results in decreased expression of PPARB protein CTD PMID:31063766 D-glucose multiple interactions ISO RGD:736289 6480464 [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA CTD PMID:32613381 daunorubicin decreases activity ISO RGD:736289 6480464 Daunorubicin results in decreased activity of PPARD protein CTD PMID:25257666 daunorubicin multiple interactions EXP 6480464 [Enalaprilat co-treated with Daunorubicin] results in increased expression of PPARD mRNA CTD PMID:23834779 deguelin decreases expression ISO RGD:736289 6480464 deguelin results in decreased expression of PPARD mRNA CTD PMID:33512557 dexamethasone increases expression ISO RGD:736289 6480464 Dexamethasone results in increased expression of PPARD mRNA CTD PMID:19022236 dexamethasone multiple interactions ISO RGD:736289 6480464 [Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA more ... CTD PMID:33476690 dexamethasone decreases expression ISO RGD:736289 6480464 Dexamethasone results in decreased expression of PPARD mRNA CTD PMID:25047013 dextran sulfate multiple interactions ISO RGD:731946 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PPARD mRNA CTD PMID:29950665 Di-n-decyl phthalate affects binding ISO RGD:736289 6480464 didecyl phthalate binds to PPARB protein CTD PMID:23843199 Di-n-hexyl phthalate affects binding ISO RGD:736289 6480464 di-n-hexyl phthalate binds to PPARB protein CTD PMID:23843199 dibenz[a,h]anthracene decreases expression ISO RGD:731946 6480464 1 more ... CTD PMID:26377693 dibutyl phthalate affects binding ISO RGD:736289 6480464 Dibutyl Phthalate binds to PPARB protein CTD PMID:23843199 dichloroacetic acid decreases expression ISO RGD:731946 6480464 Dichloroacetic Acid results in decreased expression of PPARD mRNA CTD PMID:28962523 dichloromethane decreases expression ISO RGD:731946 6480464 Methylene Chloride results in decreased expression of PPARD mRNA CTD PMID:28392392 dicrotophos increases expression ISO RGD:736289 6480464 dicrotophos results in increased expression of PPARD mRNA CTD PMID:28302478 diethyl phthalate affects binding ISO RGD:736289 6480464 diethyl phthalate binds to PPARB protein CTD PMID:23843199 diheptyl phthalate affects binding ISO RGD:736289 6480464 diheptyl phthalate binds to PPARB protein CTD PMID:23843199 Diisodecyl phthalate affects binding ISO RGD:736289 6480464 diisodecyl phthalate binds to PPARB protein CTD PMID:23843199 diisononyl phthalate affects binding ISO RGD:736289 6480464 diisononyl phthalate binds to PPARB protein CTD PMID:23843199 Dimethyl phthalate affects binding ISO RGD:736289 6480464 dimethyl phthalate binds to PPARB protein CTD PMID:23843199 dipentyl phthalate affects binding ISO RGD:736289 6480464 di-n-pentyl phthalate binds to PPARB protein CTD PMID:23843199 dipropyl phthalate affects binding ISO RGD:736289 6480464 di-n-propylphthalate binds to PPARB protein CTD PMID:23843199 doxorubicin decreases activity ISO RGD:736289 6480464 Doxorubicin results in decreased activity of PPARD protein CTD PMID:25257666 doxorubicin decreases expression ISO RGD:736289 6480464 Doxorubicin results in decreased expression of PPARD mRNA CTD PMID:16404146 , PMID:29803840 ellagic acid decreases expression ISO RGD:736289 6480464 Ellagic Acid results in decreased expression of PPARD mRNA CTD PMID:12002526 enalaprilat dihydrate multiple interactions EXP 6480464 [Enalaprilat co-treated with Daunorubicin] results in increased expression of PPARD mRNA CTD PMID:23834779 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of PPARD mRNA CTD PMID:29391264 ethanol multiple interactions ISO RGD:731946 6480464 [PPARD gene mutant form results in increased susceptibility to Ethanol] which results in increased activity of SREBF1 protein more ... CTD PMID:23851158 , PMID:27765815 ethanol increases expression ISO RGD:731946 6480464 Ethanol results in increased expression of PPARD mRNA CTD PMID:30319688 ethanol multiple interactions EXP 6480464 [Oleic Acid co-treated with Palmitic Acid co-treated with Ethanol] results in increased expression of PPARD mRNA CTD PMID:26854922 ethanol increases expression EXP 6480464 Ethanol results in increased expression of PPARD mRNA CTD PMID:26854922 ethanol multiple interactions ISO RGD:736289 6480464 Ethanol inhibits the reaction [(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1, 3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid results in increased activity of PPARB protein] CTD PMID:18003597 ethanol increases expression ISO RGD:736289 6480464 Ethanol results in increased expression of PPARB mRNA, Ethanol results in increased expression of PPARD mRNA CTD PMID:18003597 , PMID:28986285 ethanol increases response to substance ISO RGD:731946 6480464 PPARD gene mutant form results in increased susceptibility to Ethanol CTD PMID:23851158 felodipine increases activity ISO RGD:736289 6480464 Felodipine results in increased activity of PPARD protein CTD PMID:25257666 fenofibrate increases expression ISO RGD:731946 6480464 Fenofibrate results in increased expression of PPARD mRNA CTD PMID:19201410 fenofibrate increases expression ISO RGD:736289 6480464 Fenofibrate results in increased expression of PPARD mRNA CTD PMID:19201410 fluoranthene multiple interactions ISO RGD:731946 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of PPARD mRNA CTD PMID:28329830 flusilazole increases activity ISO RGD:736289 6480464 flusilazole results in increased activity of PPARD protein CTD PMID:20143881 fluvalinate affects binding ISO RGD:736289 6480464 fluvalinate binds to PPARD protein CTD PMID:32278787 fructose multiple interactions ISO RGD:731946 6480464 [PPARD mRNA results in decreased susceptibility to Fructose] which results in decreased expression of VLDLR mRNA more ... CTD PMID:29289645 fructose decreases response to substance ISO RGD:731946 6480464 PPARD mRNA results in decreased susceptibility to Fructose CTD PMID:29289645 furan increases methylation EXP 6480464 furan results in increased methylation of PPARD gene CTD PMID:22079235 furan decreases expression EXP 6480464 furan results in decreased expression of PPARD mRNA CTD PMID:26194646 gemcitabine affects expression ISO RGD:731946 6480464 Gemcitabine affects the expression of PPARD mRNA CTD PMID:19427843 gemfibrozil increases expression ISO RGD:731946 6480464 Gemfibrozil results in increased expression of PPARD mRNA CTD PMID:19201410 gemfibrozil increases expression ISO RGD:736289 6480464 Gemfibrozil results in increased expression of PPARD mRNA CTD PMID:19201410 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of PPARD mRNA CTD PMID:33387578 glucose affects expression EXP 6480464 Glucose affects the expression of PPARD mRNA CTD PMID:24349266 glucose decreases expression EXP 6480464 Glucose results in decreased expression of PPARB protein CTD PMID:31063766 glucose multiple interactions EXP 6480464 HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARB protein]], naringenin inhibits the reaction [Glucose results in decreased expression of PPARB protein] CTD PMID:31063766 glucose multiple interactions ISO RGD:736289 6480464 [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA CTD PMID:32613381 glyphosate multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PPARD mRNA CTD PMID:33854195 graphene oxide increases expression ISO RGD:731946 6480464 graphene oxide analog results in increased expression of PPARD mRNA CTD PMID:33227293 griseofulvin increases expression ISO RGD:731946 6480464 Griseofulvin results in increased expression of PPARD mRNA CTD PMID:9548566 GW 2433 affects binding ISO RGD:736289 6480464 GW 2433 binds to PPARD protein CTD PMID:17290005 GW 2433 multiple interactions ISO RGD:736289 6480464 Ro 41-5253 inhibits the reaction [GW 2433 binds to PPARD protein] CTD PMID:17290005 GW 501516 multiple interactions ISO RGD:731946 6480464 4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide inhibits the reaction [GW 501516 results in increased expression of PPARD mRNA] more ... CTD PMID:17275789 more ... GW 501516 affects binding EXP 6480464 GW 501516 binds to PPARD protein CTD PMID:18701451 GW 501516 increases expression ISO RGD:736289 6480464 GW 501516 results in increased expression of PPARD mRNA CTD PMID:19201410 GW 501516 increases activity ISO RGD:736289 6480464 GW 501516 results in increased activity of PPARD protein CTD PMID:27551952 more ... GW 501516 multiple interactions EXP 6480464 [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased activity of RELA protein] more ... CTD PMID:18701451 , PMID:19103650 GW 501516 multiple interactions ISO RGD:736289 6480464 [Calcitriol co-treated with GW 501516] results in increased expression of PPARD mRNA more ... CTD PMID:16197558 more ... GW 501516 increases activity EXP 6480464 GW 501516 results in increased activity of PPARB protein CTD PMID:19103650 GW 501516 affects binding ISO RGD:736289 6480464 GW 501516 binds to PPARB protein, GW 501516 binds to PPARD protein CTD PMID:23843199 , PMID:32407875 GW 501516 increases expression ISO RGD:731946 6480464 GW 501516 results in increased expression of PPARD mRNA CTD PMID:19201410 , PMID:20516370 GW 7647 increases activity ISO RGD:736289 6480464 GW 7647 results in increased activity of PPARD protein CTD PMID:20143881 HET0016 multiple interactions EXP 6480464 HET0016 inhibits the reaction [naringenin inhibits the reaction [Glucose results in decreased expression of PPARB protein]] CTD PMID:31063766 hexadecanoic acid multiple interactions EXP 6480464 [Oleic Acid co-treated with Palmitic Acid co-treated with Ethanol] results in increased expression of PPARD mRNA more ... CTD PMID:25048947 more ... hexadecanoic acid multiple interactions ISO RGD:736289 6480464 [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA more ... CTD PMID:30547786 , PMID:32613381 hydroquinone increases expression ISO RGD:736289 6480464 hydroquinone results in increased expression of PPARD mRNA CTD PMID:31256213 idarubicin decreases activity ISO RGD:736289 6480464 Idarubicin results in decreased activity of PPARD protein CTD PMID:25257666 imidacloprid multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PPARD mRNA CTD PMID:33854195 indometacin multiple interactions ISO RGD:736289 6480464 PPARD protein affects the reaction [Indomethacin results in decreased expression of YWHAE protein] more ... CTD PMID:17341418 , PMID:17409426 indometacin increases expression ISO RGD:736289 6480464 Indomethacin results in increased expression of PPARD mRNA, Indomethacin results in increased expression of PPARD protein CTD PMID:17341418 more ... indometacin decreases activity ISO RGD:736289 6480464 Indomethacin results in decreased activity of PPARD protein CTD PMID:10555149 indometacin decreases expression ISO RGD:736289 6480464 Indomethacin results in decreased expression of PPARD protein CTD PMID:18678619 isorhamnetin increases activity ISO RGD:736289 6480464 3-methylquercetin results in increased activity of PPARD protein CTD PMID:22992727 lacidipine increases activity ISO RGD:736289 6480464 lacidipine results in increased activity of PPARD protein CTD PMID:25257666 linoleic acid multiple interactions ISO RGD:731946 6480464 Linoleic Acid binds to and results in increased activity of PPARB protein CTD PMID:16731579 linoleic acid decreases expression ISO RGD:736289 6480464 Linoleic Acid results in decreased expression of PPARD mRNA CTD PMID:15708366 linoleic acid multiple interactions ISO RGD:736289 6480464 Linoleic Acid binds to and results in increased activity of PPARB protein CTD PMID:16731579 linoleic acid increases activity ISO RGD:736289 6480464 Linoleic Acid results in increased activity of PPARD protein CTD PMID:25786526 linoleic acid multiple interactions EXP 6480464 Linoleic Acid binds to and results in increased activity of PPARB protein CTD PMID:16731579 linoleic acid affects binding ISO RGD:736289 6480464 Linoleic Acid binds to PPARB protein CTD PMID:23843199 linoleic acid increases expression ISO RGD:736289 6480464 Linoleic Acid results in increased expression of PPARD mRNA CTD PMID:11172467 lipopolysaccharide increases expression ISO RGD:731946 6480464 Lipopolysaccharides results in increased expression of PPARD mRNA CTD PMID:27427494 lipopolysaccharide multiple interactions EXP 6480464 Lipopolysaccharides promotes the reaction [RELA protein binds to PPARD protein] CTD PMID:15728586 lipopolysaccharide multiple interactions ISO RGD:731946 6480464 (4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1, 3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid inhibits the reaction [Lipopolysaccharides results in increased expression of PPARD mRNA] CTD PMID:27427494 methotrexate decreases expression ISO RGD:736289 6480464 Methotrexate results in decreased expression of PPARD mRNA CTD PMID:17400583 methotrexate increases expression ISO RGD:736289 6480464 Methotrexate results in increased expression of PPARD mRNA CTD PMID:21678067 methoxychlor increases methylation EXP 6480464 Methoxychlor results in increased methylation of PPARD gene CTD PMID:23303685 mithramycin multiple interactions ISO RGD:736289 6480464 Plicamycin inhibits the reaction [PPARD protein results in increased expression of SIRT1 mRNA] CTD PMID:20160399 mono(2-ethylhexyl) phthalate affects expression EXP 6480464 mono-(2-ethylhexyl)phthalate affects the expression of PPARD mRNA, mono-(2-ethylhexyl)phthalate affects the expression of PPARD protein CTD PMID:15647598 mono(2-ethylhexyl) phthalate increases activity ISO RGD:736289 6480464 mono-(2-ethylhexyl)phthalate results in increased activity of PPARD protein CTD PMID:27551952 mono(2-ethylhexyl) phthalate affects binding ISO RGD:736289 6480464 mono-(2-ethylhexyl)phthalate binds to PPARB protein CTD PMID:23843199 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:731946 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARD mRNA CTD PMID:31884101 monobenzyl phthalate affects binding ISO RGD:736289 6480464 mono-benzyl phthalate binds to PPARB protein CTD PMID:23843199 monobenzyl phthalate multiple interactions ISO RGD:731946 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARD mRNA CTD PMID:31884101 monobenzyl phthalate increases activity ISO RGD:736289 6480464 mono-benzyl phthalate results in increased activity of PPARD protein CTD PMID:27551952 Monobutylphthalate affects binding ISO RGD:736289 6480464 monobutyl phthalate binds to PPARB protein CTD PMID:23843199 Monobutylphthalate multiple interactions ISO RGD:736289 6480464 monobutyl phthalate inhibits the reaction [(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1, 3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid binds to and results in increased activity of PPARD protein] CTD PMID:16326050 monoethyl phthalate multiple interactions ISO RGD:731946 6480464 [monoethyl phthalate co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-isobutyl phthalate co-treated with monoisononylphthalate co-treated with mono-benzyl phthalate] results in increased expression of PPARD mRNA CTD PMID:31884101 monoethyl phthalate affects binding ISO RGD:736289 6480464 monoethyl phthalate binds to PPARB protein CTD PMID:23843199 monohexyl phthalate affects binding ISO RGD:736289 6480464 mono-n-hexyl phthalate binds to PPARB protein CTD PMID:23843199 Monomethyl phthalate affects binding ISO RGD:736289 6480464 monomethyl phthalate binds to PPARB protein CTD PMID:23843199 monooctyl phthalate affects binding ISO RGD:736289 6480464 mono-n-octyl phthalate binds to PPARB protein CTD PMID:23843199 monosodium L-glutamate multiple interactions ISO RGD:731946 6480464 [Fats, Unsaturated co-treated with Sodium Glutamate co-treated with Aspartame] affects the expression of PPARD mRNA CTD PMID:23783067 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of PPARD mRNA CTD PMID:18164116 nemorubicin decreases activity ISO RGD:736289 6480464 methoxy-morpholinyl-doxorubicin results in decreased activity of PPARD protein CTD PMID:25257666 niclosamide increases expression ISO RGD:736289 6480464 Niclosamide results in increased expression of PPARD mRNA CTD PMID:22576131 nimesulide increases response to substance ISO RGD:731946 6480464 PPARD results in increased susceptibility to nimesulide CTD PMID:21159610 nimesulide increases expression ISO RGD:736289 6480464 nimesulide results in increased expression of PPARD mRNA, nimesulide results in increased expression of PPARD protein CTD PMID:19415698 nimesulide multiple interactions ISO RGD:731946 6480464 [[(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1 more ... CTD PMID:19748995 , PMID:21159610 NMN zwitterion multiple interactions ISO RGD:731946 6480464 Nicotinamide Mononucleotide inhibits the reaction [MIR34A mRNA results in decreased expression of PPARD mRNA] CTD PMID:23834033 norathyriol multiple interactions ISO RGD:736289 6480464 norathyriol inhibits the reaction [(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1, 3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid results in increased activity of PPARD protein] CTD PMID:18393431 octanoic acid multiple interactions ISO RGD:731946 6480464 octanoic acid binds to and results in increased activity of PPARB protein CTD PMID:16731579 octocrylene increases expression ISO RGD:736289 6480464 octocrylene results in increased expression of PPARD mRNA CTD PMID:34864131 okadaic acid increases expression ISO RGD:736289 6480464 Okadaic Acid results in increased expression of PPARD mRNA CTD PMID:31115591 oleic acid multiple interactions ISO RGD:731946 6480464 Oleic Acid binds to and results in increased activity of PPARB protein CTD PMID:16731579 oleic acid multiple interactions EXP 6480464 [Oleic Acid co-treated with Palmitic Acid co-treated with Ethanol] results in increased expression of PPARD mRNA more ... CTD PMID:16731579 more ... oleic acid decreases expression EXP 6480464 Oleic Acid results in decreased expression of PPARD mRNA CTD PMID:24349266 oleic acid multiple interactions ISO RGD:736289 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] affects the expression of PPARD mRNA more ... CTD PMID:16731579 , PMID:30547786 oleic acid increases expression ISO RGD:736289 6480464 Oleic Acid results in increased expression of PPARD mRNA CTD PMID:11172467 orlistat multiple interactions ISO RGD:736289 6480464 Orlistat inhibits the reaction [[Rosiglitazone co-treated with TF protein co-treated with INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Hydrocortisone co-treated with Triiodothyronine] results in increased expression of PPARD mRNA] CTD PMID:33476690 paracetamol increases expression ISO RGD:736289 6480464 Acetaminophen results in increased expression of PPARD mRNA CTD PMID:21420995 more ... paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of PPARD mRNA CTD PMID:33387578 parathion decreases expression ISO RGD:731946 6480464 Parathion results in decreased expression of PPARD mRNA CTD PMID:34813904 perflubutane increases expression ISO RGD:736289 6480464 perfluorobutane results in increased expression of PPARD mRNA CTD PMID:23567314 perfluorododecanoic acid increases expression ISO RGD:736289 6480464 perfluorododecanoic acid results in increased expression of PPARD mRNA CTD PMID:23567314 perfluorohexanesulfonic acid increases expression ISO RGD:736289 6480464 perfluorohexanesulfonic acid results in increased expression of PPARD mRNA CTD PMID:23567314 perfluorohexanesulfonic acid decreases expression ISO RGD:736289 6480464 perfluorohexanesulfonic acid results in decreased expression of PPARD mRNA CTD PMID:25812627 perfluorohexanoic acid increases expression ISO RGD:736289 6480464 perfluorohexanoic acid results in increased expression of PPARD mRNA CTD PMID:23567314 perfluorononanoic acid increases expression ISO RGD:736289 6480464 perfluoro-n-nonanoic acid results in increased expression of PPARD mRNA CTD PMID:23567314 perfluorononanoic acid decreases expression ISO RGD:736289 6480464 perfluoro-n-nonanoic acid results in decreased expression of PPARD mRNA CTD PMID:25812627 perfluorooctane-1-sulfonic acid increases activity ISO RGD:731946 6480464 perfluorooctane sulfonic acid results in increased activity of PPARD protein CTD PMID:17047030 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:736289 6480464 perfluorooctane sulfonic acid results in decreased expression of PPARD mRNA CTD PMID:32790152 perfluorooctanoic acid increases expression ISO RGD:731946 6480464 perfluorooctanoic acid results in increased expression of PPARB mRNA, perfluorooctanoic acid results in increased expression of PPARB protein CTD PMID:22154759 perfluorooctanoic acid multiple interactions ISO RGD:736289 6480464 perfluorooctanoic acid inhibits the reaction [PPARD protein inhibits the reaction [PPARA protein results in increased expression of FA2H mRNA]], perfluorooctanoic acid inhibits the reaction [PPARD protein results in decreased activity of PPARA protein] CTD PMID:35370244 perfluorooctanoic acid decreases expression ISO RGD:736289 6480464 perfluorooctanoic acid results in decreased expression of PPARD mRNA CTD PMID:23567314 more ... perfluorooctanoic acid increases activity ISO RGD:736289 6480464 perfluorooctanoic acid results in increased activity of PPARD protein CTD PMID:23391484 perfluorooctanoic acid decreases expression ISO RGD:731946 6480464 perfluorooctanoic acid results in decreased expression of PPARB mRNA more ... CTD PMID:22154759 , PMID:30711707 perfluorooctanoic acid increases activity ISO RGD:731946 6480464 perfluorooctanoic acid results in increased activity of PPARD protein CTD PMID:17047030 perfluorooctanoic acid multiple interactions ISO RGD:731946 6480464 perfluorooctanoic acid binds to and results in increased activity of PPARB protein CTD PMID:16731579 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of PPARD mRNA CTD PMID:31324951 phenobarbital affects expression ISO RGD:731946 6480464 Phenobarbital affects the expression of PPARD mRNA CTD PMID:23091169 phenylephrine multiple interactions EXP 6480464 [4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid results in increased activity of PPARD protein] which results in decreased susceptibility to Phenylephrine more ... CTD PMID:15721863 , PMID:18701451 phorbol 13-acetate 12-myristate increases expression ISO RGD:731946 6480464 Tetradecanoylphorbol Acetate results in increased expression of PPARD mRNA CTD PMID:10866668 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:731946 6480464 PPARD protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of CCNB1 mRNA] more ... CTD PMID:10866668 phthalic acid affects binding ISO RGD:736289 6480464 phthalic acid binds to PPARB protein CTD PMID:23843199 phytanic acid affects binding ISO RGD:736289 6480464 Phytanic Acid binds to PPARB protein CTD PMID:23843199 pioglitazone increases expression ISO RGD:731946 6480464 pioglitazone results in increased expression of PPARD mRNA CTD PMID:19201410 pioglitazone increases activity ISO RGD:736289 6480464 pioglitazone results in increased activity of PPARD protein CTD PMID:23150725 pioglitazone multiple interactions ISO RGD:736289 6480464 pioglitazone results in increased activity of [PPARD protein binds to RXRA protein] CTD PMID:11779144 pioglitazone increases expression ISO RGD:736289 6480464 pioglitazone results in increased expression of PPARD mRNA CTD PMID:19201410 pioglitazone affects binding ISO RGD:736289 6480464 pioglitazone binds to PPARB protein, pioglitazone binds to PPARD protein CTD PMID:11779144 , PMID:23843199 Pirarubicin decreases activity ISO RGD:736289 6480464 pirarubicin results in decreased activity of PPARD protein CTD PMID:25257666 pirinixic acid multiple interactions ISO RGD:731946 6480464 [pirinixic acid results in increased activity of PPARD protein] which results in increased expression of NFKBIA mRNA more ... CTD PMID:19438714 , PMID:8700121 pirinixic acid increases activity ISO RGD:736289 6480464 pirinixic acid results in increased activity of PPARD protein CTD PMID:26135921 , PMID:9703482 pirinixic acid increases expression ISO RGD:736289 6480464 pirinixic acid results in increased expression of PPARD mRNA CTD PMID:19667161 pirinixic acid multiple interactions ISO RGD:736289 6480464 [Calcitriol co-treated with pirinixic acid] results in increased expression of PPARD mRNA, [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of PPARD mRNA CTD PMID:19667161 , PMID:19710929 pitavastatin increases expression ISO RGD:736289 6480464 pitavastatin results in increased expression of PPARD mRNA CTD PMID:21554872 pitavastatin(1-) increases expression ISO RGD:736289 6480464 pitavastatin results in increased expression of PPARD mRNA CTD PMID:21554872 prostaglandin E2 multiple interactions ISO RGD:731946 6480464 [[nimesulide results in decreased activity of PTGS2 protein] co-treated with [(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1 more ... CTD PMID:19748995 quercetin multiple interactions ISO RGD:736289 6480464 Quercetin inhibits the reaction [(4-(((2-(3-fluoro-4-(trifluoromethyl)phenyl)-4-methyl-1, 3-thiazol-5-yl)methyl)sulfanyl)-2-methylphenoxy)acetic acid results in increased activity of PPARD protein] CTD PMID:18393431 rac-lactic acid decreases expression ISO RGD:736289 6480464 Lactic Acid results in decreased expression of PPARD mRNA CTD PMID:30851411 rebaudioside A multiple interactions ISO RGD:731946 6480464 rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARD mRNA] CTD PMID:25554529 resveratrol decreases expression ISO RGD:736289 6480464 resveratrol results in decreased expression of PPARD mRNA CTD PMID:12002526 , PMID:12569576 resveratrol multiple interactions ISO RGD:731946 6480464 [Dietary Fats co-treated with Resveratrol] results in increased expression of PPARD mRNA CTD PMID:29197120 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of PPARD CTD PMID:23790948 resveratrol increases expression ISO RGD:736289 6480464 resveratrol analog results in increased expression of PPARD mRNA CTD PMID:24759758 resveratrol multiple interactions EXP 6480464 [Dietary Fats co-treated with resveratrol] affects the expression of PPARD mRNA, resveratrol inhibits the reaction [Dietary Fats results in decreased expression of PPARD protein] CTD PMID:26055348 Ro 41-5253 affects binding ISO RGD:736289 6480464 Ro 41-5253 binds to PPARD protein CTD PMID:17290005 Ro 41-5253 multiple interactions ISO RGD:736289 6480464 Ro 41-5253 inhibits the reaction [GW 2433 binds to PPARD protein] CTD PMID:17290005 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of PPARD mRNA CTD PMID:28374803 rotenone decreases expression ISO RGD:736289 6480464 Rotenone results in decreased expression of PPARD mRNA CTD PMID:33512557 rutin multiple interactions EXP 6480464 Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARD mRNA], Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARD protein] CTD PMID:25478064 SB 203580 multiple interactions ISO RGD:736289 6480464 SB 203580 inhibits the reaction [Indomethacin results in increased expression of PPARD protein] CTD PMID:17341418 sirolimus multiple interactions ISO RGD:731946 6480464 PPARD protein affects the reaction [[Sirolimus co-treated with HRAS protein] results in decreased expression of ERN1 protein], PPARD protein affects the reaction [[Sirolimus co-treated with HRAS protein] results in decreased expression of HSPA5 protein] CTD PMID:24898257 Sodium oleate multiple interactions ISO RGD:736289 6480464 [osteum co-treated with Palmitic Acid co-treated with Glucose co-treated with INS protein co-treated with TNF protein co-treated with IL1B protein co-treated with TNF protein] results in increased expression of PPARD mRNA CTD PMID:32613381 Soman increases expression EXP 6480464 Soman results in increased expression of PPARD mRNA CTD PMID:19281266 steviol multiple interactions ISO RGD:731946 6480464 steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARD mRNA] CTD PMID:25554529 stevioside multiple interactions ISO RGD:731946 6480464 stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARD mRNA] CTD PMID:25554529 streptozocin decreases expression EXP 6480464 Streptozocin results in decreased expression of PPARD mRNA CTD PMID:25246140 streptozocin multiple interactions ISO RGD:731946 6480464 [Streptozocin co-treated with Dietary Fats co-treated with Carboxymethylcellulose Sodium] results in decreased expression of PPARB protein, naringenin inhibits the reaction [[Streptozocin co-treated with Dietary Fats co-treated with Carboxymethylcellulose Sodium] results in decreased expression of PPARB protein] CTD PMID:31063766 streptozocin multiple interactions EXP 6480464 olive oil inhibits the reaction [Streptozocin results in decreased expression of PPARD mRNA] CTD PMID:25246140 sulindac affects response to substance ISO RGD:731946 6480464 PPARD protein affects the susceptibility to Sulindac CTD PMID:10866668 sulindac increases expression ISO RGD:736289 6480464 Sulindac results in increased expression of PPARD protein CTD PMID:21400612 sulindac sulfide multiple interactions ISO RGD:736289 6480464 PPARD protein affects the reaction [sulindac sulfide results in decreased expression of YWHAE protein] more ... CTD PMID:16091736 , PMID:17409426 sulindac sulfide increases expression ISO RGD:736289 6480464 sulindac sulfide results in increased expression of PPARD mRNA, sulindac sulfide results in increased expression of PPARD protein CTD PMID:11948457 , PMID:21400612 sulindac sulfide decreases activity ISO RGD:736289 6480464 sulindac sulfide results in decreased activity of PPARD protein CTD PMID:10555149 sulindac sulfide decreases expression ISO RGD:736289 6480464 sulindac sulfide results in decreased expression of PPARD mRNA, sulindac sulfide results in decreased expression of PPARD protein CTD PMID:17409426 , PMID:18678619 sulindac sulfone increases expression ISO RGD:736289 6480464 sulindac sulfone results in increased expression of PPARD mRNA CTD PMID:11948457 sunitinib increases expression ISO RGD:736289 6480464 Sunitinib results in increased expression of PPARD mRNA CTD PMID:31533062 tebufenpyrad decreases expression ISO RGD:736289 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of PPARD mRNA CTD PMID:33512557 telmisartan increases expression ISO RGD:731946 6480464 telmisartan results in increased expression of PPARD protein CTD PMID:20176998 telmisartan increases expression EXP 6480464 telmisartan results in increased expression of PPARD protein CTD PMID:20176998 telmisartan multiple interactions ISO RGD:731946 6480464 PPARD promotes the reaction [telmisartan results in increased expression of LIPE protein] more ... CTD PMID:20176998 tert-butyl hydroperoxide increases expression ISO RGD:736289 6480464 tert-Butylhydroperoxide results in increased expression of PPARD mRNA CTD PMID:15336504 Tetrachlorobisphenol A affects binding ISO RGD:736289 6480464 tetrachlorodian binds to PPARD protein CTD PMID:34627044 tetrachloroethene decreases expression ISO RGD:731946 6480464 Tetrachloroethylene results in decreased expression of PPARD mRNA CTD PMID:28973375 tetrachloromethane affects response to substance ISO RGD:731946 6480464 PPARD protein affects the susceptibility to Carbon Tetrachloride CTD PMID:18622026 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of PPARB mRNA CTD PMID:31150632 tetrachloromethane decreases activity EXP 6480464 Carbon Tetrachloride results in decreased activity of PPARD protein CTD PMID:25858767 tetrachloromethane multiple interactions ISO RGD:731946 6480464 PPARD protein affects the reaction [Carbon Tetrachloride results in increased expression of BAX mRNA] more ... CTD PMID:18038451 , PMID:18622026 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of PPARD mRNA, Carbon Tetrachloride results in decreased expression of PPARD protein CTD PMID:25478064 tetrachloromethane multiple interactions EXP 6480464 Rutin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARD mRNA] more ... CTD PMID:25478064 , PMID:31150632 thalidomide increases response to substance ISO RGD:736289 6480464 PPARD gene SNP results in increased susceptibility to Thalidomide CTD PMID:21245421 thiabendazole multiple interactions EXP 6480464 [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PPARD mRNA CTD PMID:33854195 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of PPARD mRNA CTD PMID:34492290 titanium dioxide multiple interactions ISO RGD:731946 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of PPARD mRNA CTD PMID:29950665 trichloroethene decreases expression ISO RGD:731946 6480464 Trichloroethylene results in decreased expression of PPARD mRNA CTD PMID:28973375 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of PPARD mRNA CTD PMID:33387578 triphenylstannane decreases expression EXP 6480464 triphenyltin results in decreased expression of PPARD mRNA, triphenyltin results in decreased expression of PPARD protein CTD PMID:32504733 Triptolide decreases expression ISO RGD:731946 6480464 triptolide results in decreased expression of PPARD protein CTD PMID:26219505 Triptolide increases expression ISO RGD:731946 6480464 triptolide results in increased expression of PPARD mRNA CTD PMID:32835833 tunicamycin increases response to substance ISO RGD:731946 6480464 PPARD gene mutant form results in increased susceptibility to Tunicamycin CTD PMID:29289645 tunicamycin multiple interactions ISO RGD:731946 6480464 [PPARD gene mutant form results in increased susceptibility to Tunicamycin] which results in increased expression of NQO1 mRNA more ... CTD PMID:29289645 tyrphostin AG 1478 multiple interactions ISO RGD:736289 6480464 RTKI cpd inhibits the reaction [antimonite results in increased expression of PPARD mRNA], RTKI cpd inhibits the reaction [arsenite results in increased expression of PPARD mRNA] CTD PMID:17400267 urethane increases expression ISO RGD:736289 6480464 Urethane results in increased expression of PPARD mRNA CTD PMID:28818685 valproic acid multiple interactions ISO RGD:736289 6480464 Valproic Acid binds to and results in increased activity of PPARD protein CTD PMID:24489787 valproic acid increases methylation ISO RGD:736289 6480464 Valproic Acid results in increased methylation of PPARD gene CTD PMID:29501571 valproic acid increases expression ISO RGD:736289 6480464 Valproic Acid results in increased expression of PPARD mRNA CTD PMID:24935251 , PMID:29501571 wortmannin multiple interactions EXP 6480464 wortmannin inhibits the reaction [bisphenol A results in decreased expression of PPARD mRNA] CTD PMID:23399309 zinc atom multiple interactions ISO RGD:736289 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of PPARD mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:736289 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of PPARD mRNA CTD PMID:18593933 zoledronic acid increases expression ISO RGD:736289 6480464 zoledronic acid results in increased expression of PPARD mRNA CTD PMID:24714768